CHLORTHALIDONE
- Product NDC
- 53002-1623
- 11-digit product format
- 530021623
- Labeler code
- 53002
- Product ID
- 53002-1623_449028a8-d660-4e80-8498-c0778f87d513
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CHLORTHALIDONE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA206904
- Marketing category
- ANDA
- Marketing start
- 2017-05-17
- Marketing end
- 0000-00-00
- Substance
- CHLORTHALIDONE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Thiazide-like Diuretic [EPC],Increased Diuresis [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 53002-1623-0 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-17d7-f424-e053-dadaa90a57ce | CHLORTHALIDONE TABLETS USP, 25 mg and 50 mg |
| 53002-1623-3 | 2025-01-30 | C162847 | 48780-1 | 9d75b9d0-17d7-f424-e053-dadaa90a57ce | CHLORTHALIDONE TABLETS USP, 25 mg and 50 mg |
| 53002-1623-0 | 2023-06-07 | C162847 | 48780-1 | 9d75b9d0-17d7-f424-e053-dadaa90a57ce | CHLORTHALIDONE TABLETS USP, 25 mg and 50 mg |
| 53002-1623-3 | 2023-06-07 | C162847 | 48780-1 | 9d75b9d0-17d7-f424-e053-dadaa90a57ce | CHLORTHALIDONE TABLETS USP, 25 mg and 50 mg |
| 53002-1623-0 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-17d7-f424-e053-dadaa90a57ce | CHLORTHALIDONE TABLETS USP, 25 mg and 50 mg |
| 53002-1623-3 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-17d7-f424-e053-dadaa90a57ce | CHLORTHALIDONE TABLETS USP, 25 mg and 50 mg |
| 53002-1623-0 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-17d7-f424-e053-dadaa90a57ce | CHLORTHALIDONE TABLETS USP, 25 mg and 50 mg |
| 53002-1623-3 | 2020-12-15 | C162847 | 48780-1 | 9d75b9d0-17d7-f424-e053-dadaa90a57ce | CHLORTHALIDONE TABLETS USP, 25 mg and 50 mg |
| 53002-1623-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-17d7-f424-e053-dadaa90a57ce | CHLORTHALIDONE TABLETS USP, 25 mg and 50 mg |
| 53002-1623-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-17d7-f424-e053-dadaa90a57ce | CHLORTHALIDONE TABLETS USP, 25 mg and 50 mg |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-1623-0 | CHLORTHALIDONE | 100 in 1 BOTTLE | TABLET | 100 | | 5 |
| 53002-1623-3 | CHLORTHALIDONE | 30 in 1 BOTTLE | TABLET | 30 | | 5 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-1623 | CHLORTHALIDONE TABLET [RPK PHARMACEUTICALS, INC.] | 5 | Legacy NDC, 2 package rows | 20230609_9b5c2ff4-d427-4f37-826a-7bac6abad735.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-1623-0 | 53002162300 | 100 TABLET in 1 BOTTLE (53002-1623-0) | 100 tablet | 2017-09-01 | 0000-00-00 | No | No | Current |
| 53002-1623-3 | 53002162303 | 30 TABLET in 1 BOTTLE (53002-1623-3) | 30 tablet | 2017-09-01 | 0000-00-00 | No | No | Current |